| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9961083 | Journal of the American College of Cardiology | 2005 | 7 Pages |
Abstract
In this analysis, there is no clearly demonstrable mortality benefit conferred by MVA for significant MR with severe LV dysfunction. A prospective randomized control trial is warranted for further study of mortality with MVA in this population.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Audrey H. MD, MPH, Keith D. MD, MS, Steven F. MD, FACC, Francis D. MD, PhD, FACC, Kathy MS, MPH, Todd M. MD, FACC,